law17361

Chapter 361

2017 -- S 0893
Enacted 09/29/2017

A N A C T

RELATING TO INSURANCE - ACCIDENT AND SICKNESS INSURANCE POLICIES

Introduced By: Senators Crowley, Sosnowski, Quezada, and Miller

Date Introduced: May 11, 2017

It is enacted by the General Assembly as follows:

SECTION 1. Section 27-18-50 of the General Laws in Chapter 27-18 entitled "Accident

and Sickness Insurance Policies" is hereby amended to read as follows:

27-18-50. Drug coverage. [Effective January 1, 2017.]

(a) Any accident and sickness insurer that utilizes a formulary of medications for which

coverage is provided under an individual or group-plan, master contract shall require any

physician or other person authorized by the department of health to prescribe medication to

prescribe from the formulary. A physician or other person authorized by the department of health

to prescribe medication shall be allowed to prescribe medications previously on, or not on, the

accident and sickness insurer's formulary if he or she believes that the prescription of the non-

formulary medication is medically necessary. An accident and sickness insurer shall be required

to provide coverage for a non-formulary medication only when the non-formulary medication

meets the accident and sickness insurer's medical-exception criteria for the coverage of that

medication.

(b) An accident and sickness insurer's medical exception criteria for the coverage of non-

formulary medications shall be developed in accordance with § 23-17.13-3(c)(3).

section may appeal the denial in accordance with the rules and regulations promulgated by the

department of health pursuant to chapter 17.12 of title 23.

(d) Prior to removing a prescription drug from its plan's formulary or making any change

in the preferred or tiered, cost-sharing status of a covered prescription drug, an accident and

sickness insurer must provide at least thirty (30) days' notice to authorized prescribers by

established communication methods of policy and program updates and by updating available

references on web-based publications. All adversely affected members must be provided at least

thirty (30) days' notice prior to the date such change becomes effective by a direct notification:

(i) The written or electronic notice must contain the following information:

(A) The name of the affected prescription drug;

(B) Whether the plan is removing the prescription drug from the formulary, or changing

its preferred or tiered, cost-sharing status; and

exception, in the case of drugs that will require prior authorization or are formulary exclusions

respectively.

(ii) An accident and sickness insurer may immediately remove from its plan formularies

covered prescription drugs deemed unsafe by the accident and sickness insurer or the Food and

Drug Administration, or removed from the market by their manufacturer, without meeting the

requirements of this section.

(e) This section shall not apply to insurance coverage providing benefits for: (1)

hHospital confinement indemnity; (2) dDisability income; (3) aAccident only; (4) lLong-term

care; (5) Medicare supplement; (6) lLimited-benefit health; (7) sSpecified-disease indemnity; (8)

sSickness or bodily injury or death by accident or both; or (9) oOther limited-benefit policies.

SECTION 2. Section 27-19-42 of the General Laws in Chapter 27-19 entitled "Nonprofit

Hospital Service Corporations" is hereby amended to read as follows:

27-19-42. Drug coverage. [Effective January 1, 2017.]

(a) Any nonprofit, hospital-service corporation that utilizes a formulary of medications

for which coverage is provided under an individual or group-plan, master contract shall require

any physician or other person authorized by the department of health to prescribe medication to

prescribe from the formulary. A physician or other person authorized by the department of health

to prescribe medication shall be allowed to prescribe medications previously on, or not on, the

nonprofit, hospital-service corporation's formulary if he or she believes that the prescription of

the non-formulary medication is medically necessary. A nonprofit, hospital-service corporation

shall be required to provide coverage for a non-formulary medication only when the non-

formulary medication meets the nonprofit, hospital-service corporation's medical-exception

criteria for the coverage of that medication.

(b) A nonprofit, hospital-service corporation's medical-exception criteria for the coverage

of non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3).

section may appeal the denial in accordance with the rules and regulations promulgated by the

department of health pursuant to chapter 17.12 of title 23.

(d) Prior to removing a prescription drug from its plan's formulary or making any change

in the preferred or tiered cost-sharing status of a covered prescription drug, a nonprofit, hospital-

service corporation must provide at least thirty (30) days' notice to authorized prescribers by

established communication methods of policy and program updates and by updating available

references on web-based publications. All adversely affected members must be provided at least

thirty (30) days' notice prior to the date such change becomes effective by a direct notification:

(i) The written or electronic notice must contain the following information:

(A) The name of the affected prescription drug;

(B) Whether the plan is removing the prescription drug from the formulary, or changing

its preferred or tiered, cost-sharing status; and

exception, in the case of drugs that will require prior authorization or are formulary exclusions

respectively.

(ii) A nonprofit, hospital-service corporation may immediately remove from its plan

formularies covered prescription drugs deemed unsafe by the nonprofit, hospital-service

corporation or the Food and Drug Administration, or removed from the market by their

manufacturer, without meeting the requirements of this section.

SECTION 3. Section 27-20-37 of the General Laws in Chapter 27-20 entitled "Nonprofit

Medical Service Corporations" is hereby amended to read as follows:

27-20-37. Drug coverage. [Effective January 1, 2017.]

(a) Any nonprofit, medical-service corporation that utilizes a formulary of medications

for which coverage is provided under an individual or group-plan, master contract shall require

any physician or other person authorized by the department of health to prescribe medication to

prescribe from the formulary. A physician or other person authorized by the department of health

to prescribe medication shall be allowed to prescribe medications previously on, or not on, the

nonprofit, medical-service corporation's formulary if he or she believes that the prescription of

the non-formulary medication is medically necessary. A nonprofit, hospital medical-service

corporation shall be required to provide coverage for a non-formulary medication only when the

non-formulary medication meets the nonprofit, medical-service corporation's medical-exception

criteria for the coverage of that medication.

(b) A nonprofit, medical-service corporation's medical-exception criteria for the coverage

of non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3).

section may appeal the denial in accordance with the rules and regulations promulgated by the

department of health pursuant to chapter 17.12 of title 23.

(d) Prior to removing a prescription drug from its plan's formulary or making any change

in the preferred or tiered, cost-sharing status of a covered prescription drug, a nonprofit, medical-

service corporation must provide at least thirty (30) days' notice to authorized prescribers by

established communication methods of policy and program updates and by updating available

references on web-based publications. All adversely affected members must be provided at least

thirty (30) days' notice prior to the date such change becomes effective by a direct notification:

(i) The written or electronic notice must contain the following information:

(A) The name of the affected prescription drug;

(B) Whether the plan is removing the prescription drug from the formulary, or changing

its preferred or tiered, cost-sharing status; and

exception, in the case of drugs that will require prior authorization or are formulary exclusions

respectively.

(ii) A nonprofit, medical-service corporation may immediately remove from its plan

formularies covered prescription drugs deemed unsafe by the nonprofit, medical-service

corporation or the Food and Drug Administration, or removed from the market by their

manufacturer, without meeting the requirements of this section.

SECTION 4. Section 27-20.1-15 of the General Laws in Chapter 27-20.1 entitled

"Nonprofit Dental Service Corporations" is hereby amended to read as follows:

27-20.1-15. Drug coverage. [Effective January 1, 2017.]

(a) Any nonprofit, dental-service corporation that utilizes a formulary of medications for

which coverage is provided under an individual or group-plan, master contract shall require any

physician or other person authorized by the department of health to prescribe medication to

prescribe from the formulary. A physician or other person authorized by the department of health

to prescribe medication shall be allowed to prescribe medications previously on, or not on, the

nonprofit, dental-service corporation's formulary if he or she believes that the prescription of the

non-formulary medication is medically necessary. A nonprofit, dental-service corporation shall be

required to provide coverage for a non-formulary medication only when the non-formulary

medication meets the nonprofit, dental-service corporation's medical-exception criteria for the

coverage of that medication.

(b) A nonprofit, dental-service corporation's medical-exception criteria for the coverage

of non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3).

section may appeal the denial in accordance with the rules and regulations promulgated by the

department of health pursuant to chapter 17.12 of title 23.

(d) Prior to removing a prescription drug from its plan's formulary or making any change

in the preferred or tiered, cost-sharing status of a covered prescription drug, a nonprofit, dental-

service corporation must provide at least thirty (30) days' notice to authorized prescribers by

established communication methods of policy and program updates and by updating available

references on web-based publications. All adversely affected members must be provided at least

thirty (30) days' notice prior to the date such change becomes effective by a direct notification:

(i) The written or electronic notice must contain the following information:

(A) The name of the affected prescription drug;

(B) Whether the plan is removing the prescription drug from the formulary, or changing

its preferred or tiered, cost-sharing status; and

exception, in the case of drugs that will require prior authorization or are formulary exclusions

respectively.

(ii) A nonprofit, dental-service corporation may immediately remove from its plan

formularies covered prescription drugs deemed unsafe by the nonprofit, dental-service

corporation or the Food and Drug Administration, or removed from the market by their

manufacturer, without meeting the requirements of this section.

SECTION 5. Section 27-41-51 of the General Laws in Chapter 27-41 entitled "Health

Maintenance Organizations" is hereby amended to read as follows:

27-41-51. Drug coverage. [Effective January 1, 2017.]

(a) Any health-maintenance organization that utilizes a formulary of medications for

which coverage is provided under an individual or group-plan, master contract shall require any

physician or other person authorized by the department of health to prescribe medication to

prescribe from the formulary. A physician or other person authorized by the department of health

to prescribe medication shall be allowed to prescribe medications previously on, or not on, the

health-maintenance organization's formulary if he or she believes that the prescription of non-

formulary medication is medically necessary. A health-maintenance organization shall be

required to provide coverage for a non-formulary medication only when the non-formulary

medication meets the health-maintenance organization's medical-exception criteria for the

coverage of that medication.

(b) A health-maintenance organization's medical-exception criteria for the coverage of

non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3).

section may appeal the denial in accordance with the rules and regulations promulgated by the

department of health pursuant to chapter 17.12 of title 23.

(d) Prior to removing a prescription drug from its plan's formulary or making any change

in the preferred or tiered, cost-sharing status of a covered prescription drug, a health-maintenance

organization must provide at least thirty (30) days' notice to authorized prescribers by established

communication methods of policy and program updates and by updating available references on

web-based publications. All adversely affected members must be provided at least thirty (30)

days' notice prior to the date such change becomes effective by a direct notification:

(i) The written or electronic notice must contain the following information:

(A) The name of the affected prescription drug;

(B) Whether the plan is removing the prescription drug from the formulary, or changing

its preferred or tiered, cost-sharing status; and

exception, in the case of drugs that will require prior authorization or are formulary exclusions

respectively.

(ii) A health-maintenance organization may immediately remove from its plan

formularies covered prescription drugs deemed unsafe by the health-maintenance organization or

the Food and Drug Administration, or removed from the market by their manufacturer, without

meeting the requirements of this section.

SECTION 6. This act shall take effect upon passage.

========

LC002655

========